Skip to main content

Advertisement

Log in

Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force

  • Published:
Journal of Muscle Research & Cell Motility Aims and scope Submit manuscript

Abstract

Of the two corticotropin releasing factor receptors known, corticotrophin releasing factor 2 receptor (CRF2R) is expressed in skeletal muscle. The function of this receptor in skeletal muscle is at present unknown. In order to better understand the role of the CRF2R in skeletal muscle, we treated rats with CRF2R agonists and evaluated the effect of these agents on normal and denervated muscle mass. Rats treated with the non-selective CRFR agonist, sauvagine, did not demonstrate any significant and consistent change in non-denervated and denervated fast twitch [tibialis anterior (TA) or extensor digitorum longus (EDL)] or slow/mixed twitch [medial gastrocnemius (MG) or soleus] fiber muscle mass. In adrenalectomized rats, sauvagine treatment resulted in no significant and consistent change in non-denervated fast or slow/mixed twitch fiber muscles but did cause a significant and consistent increase in denervated fast twitch (TA and EDL) but not slow/mixed twitch muscle mass. Interestingly adrenalectomy had no effect on the degree of muscle atrophy. Rats treated with the CRF2R selective agonist urocortin 2 demonstrated an increase in non-denervated and denervated fast and slow/mix twitch fiber muscle mass. The urocortin 2 induced increase in muscle mass was accompanied by an increase in muscle fiber cross-sectional area and muscle absolute force. These studies demonstrated that activation of the CRF2R decreased the level of skeletal muscle mass, force, and myocyte cross-sectional area loss resulting from sciatic nerve damage and increased the mass, force and myocyte cross-sectional area of normal (non-atrophying) skeletal muscle. In addition, we also observed that removal of the adrenals increased the effectiveness of the non-selective CRFR agonists sauvagine, presumably via the removal of the pro-atrophy influence of adrenal produced corticosteroids. These results demonstrate that pharmacological modulation of the CRF2R may be a viable method to treat skeletal muscle atrophy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • S Aboudrar B Sempore H Koubi H Dechaud D Desplanches (1993) ArticleTitleEffects of adrenalectomy or RU-486 on rat muscle fibers during hindlimb suspension J Appl Physiol 75 2767–2773 Occurrence Handle8125901

    PubMed  Google Scholar 

  • HJ Appell (1990) ArticleTitleMuscular atrophy following immobilization Sports Med 10 42–58 Occurrence Handle2197699

    PubMed  Google Scholar 

  • TL Bale FJ Giordano RP Hickey Y Huang AK Nath KL Peterson WW Vale KF Lee (2002) ArticleTitleCorticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization Proc Natl Acad Sci USA 99 7734–7739 Occurrence Handle10.1073/pnas.102187099 Occurrence Handle12032352

    Article  PubMed  Google Scholar 

  • SE Borst DT Lowenthal (1997) ArticleTitleRole of IGF-I in muscular atrophy of aging Endocrine 7 61–63 Occurrence Handle9449034

    PubMed  Google Scholar 

  • BK Brar A Chen MH Perrin W Vale (2004) ArticleTitleSpecificity and regulation of extracellulary regulated kinase1/2 phosphorylation through corticotrophin-releasing factor (CRF) receptors 1 and 2β by the CRF/Urocortin family of peptides Endocrinology 145 1718–1729 Occurrence Handle10.1210/en.2003-1023 Occurrence Handle14670995

    Article  PubMed  Google Scholar 

  • JG Cannon (1995) ArticleTitleCytokines in aging and muscle homeostasis J Gerontol A Biol Sci Med Sci 50 120–123 Occurrence Handle7493204

    PubMed  Google Scholar 

  • N Carbo J Lopez-Soriano P Costelli S Busquets B Alvarez FM Baccino LS Quinn FJ Lopez-Soriano JM Argiles (2000) ArticleTitleInterleukin-15 antagonizes muscle protein waste in tumour-bearing rats Br J Cancer 83 526–531 Occurrence Handle10.1054/bjoc.2000.1299 Occurrence Handle10945502

    Article  PubMed  Google Scholar 

  • Chen A, Vaughan J and Vale WW (2003) Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin releasing factor receptor pathways. Mol Endocrinol 10: 1210/me.2003-0054.

  • RN Cooney SR Kimball TC Vary (1997) ArticleTitleRegulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators Shock 7 1–16 Occurrence Handle8989831

    PubMed  Google Scholar 

  • SC Coste RA Kesterson KA Heldwein SL Stevens AD Heard JH Hollis SE Murray JK Hill GA Pantely AR Hohimer DC Hatton TJ Phillips DA Finn MJ Low MB Rittenberg P Stenzel MP Stenzel-Poore (2000) ArticleTitleAbnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor 2 Nat Gent 24 403–409 Occurrence Handle10.1038/74255

    Article  Google Scholar 

  • FM Dautzenberg S Wille R Lohmann J Spiess (1998) ArticleTitleMapping of the ligand-selective domain of the Xenopus laevis corticotrophin-releasing factor receptor 1: implications for the ligand binding site Proc Natl Acad Sci USA 95 4941–4946 Occurrence Handle10.1073/pnas.95.9.4941 Occurrence Handle9560207

    Article  PubMed  Google Scholar 

  • FM Dautzenberg RL Hauger (2002) ArticleTitleThe CRF peptide family and their receptors: yet more partners discovered Trends Pharmacol Sci 23 71–77 Occurrence Handle10.1016/S0165-6147(02)01946-6 Occurrence Handle11830263

    Article  PubMed  Google Scholar 

  • EB Souza ParticleDe (1995) ArticleTitleCorticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders Psychoneuroendocrinology 20 789–819 Occurrence Handle10.1016/0306-4530(95)00011-9 Occurrence Handle8834089

    Article  PubMed  Google Scholar 

  • J Garzon V Hollt R Schulz A Herz (1985) ArticleTitleExcitatory neuropeptides activate opioid mechanisms in the guinea pig ileum Neuropeptides 5 583–586 Occurrence Handle10.1016/0143-4179(85)90085-X Occurrence Handle2582305

    Article  PubMed  Google Scholar 

  • DK Grammatopoulos HS Randeva MA Levine ES Katsanou EW Hillhouse (2000) ArticleTitleUrocortin, but not corticotrophin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins Mol Endocrinol 14 2076–2091 Occurrence Handle10.1210/me.14.12.2076 Occurrence Handle11117536

    Article  PubMed  Google Scholar 

  • K Hachisuka Y Umezu H Ogata (1997) ArticleTitleDisuse muscle atrophy of lower limbs in hemiplegic patients Arch Phys Med Rehabil 78 13–18 Occurrence Handle10.1016/S0003-9993(97)90003-4 Occurrence Handle9014951

    Article  PubMed  Google Scholar 

  • KA Heldwein JE Duncan P Stenzel MB Rittenberg MP Stenzel-Poore (1997) ArticleTitleEndotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle Mol Cell Endocrinol 131 167–172 Occurrence Handle10.1016/S0303-7207(97)00103-2 Occurrence Handle9296375

    Article  PubMed  Google Scholar 

  • JT Henderson BJ Mullen JC Roder (1996) ArticleTitlePhysiological effects of CNTF-induced wasting Cytokine 8 784–793 Occurrence Handle10.1006/cyto.1996.0104 Occurrence Handle8980880

    Article  PubMed  Google Scholar 

  • I Heymann-Monnikes Y Tache M Trauner H Weiner T Garrick (1991) ArticleTitleCRF microinjected into the dorsal vagal complex inhibits TRH analog-and kainic acid-stimulated gastric contractility in rats Brain Res 554 139–144 Occurrence Handle10.1016/0006-8993(91)90181-T Occurrence Handle1933296

    Article  PubMed  Google Scholar 

  • RT Hinkle E Donnelly DB Cody S Samuelsson JS Lange MB Bauer M Tarnopolsky RJ Sheldon SC Coste E Tobar MP Stenzel-Poore RJ Isfort (2003a) ArticleTitleActivation of the CRF 2 receptor modulates skeletal muscle mass under physiological and pathological conditions Am J Physiol Endocrinol Metab 285 E889–E898

    Google Scholar 

  • RT Hinkle E Donnelly DB Cody MB Bauer RJ Isfort (2003b) ArticleTitleUrocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases non-atrophying skeletal muscle mass and function Endocrinology 144 4939–4946 Occurrence Handle10.1210/en.2003-0271

    Article  Google Scholar 

  • SY Hsu AJ Hsueh (2001) ArticleTitleHuman stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor Nat Med 7 605–611 Occurrence Handle10.1038/87936 Occurrence Handle11329063

    Article  PubMed  Google Scholar 

  • F Kanada S Okuda T Matsushita K Takatani KI Kimura K Chihara (2001) ArticleTitleSteroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor I administration Horm Res 56 24–28 Occurrence Handle10.1159/000048130 Occurrence Handle11786681

    Article  PubMed  Google Scholar 

  • K Kanada S Omori C Yamamoto N Miyamoto S Kawano Y Murata N Matsui H Seo (1993) ArticleTitleUrinary excretion of stress hormones of rats in tail-suspension Environ Med 37 39–41 Occurrence Handle12269350

    PubMed  Google Scholar 

  • N Kihara M Fujimura I Yamamoto E Itoh A Inui M Fujimiya (2001) ArticleTitleEffects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats Am J Physiol Gastrointest Liver Physiol 280 G406–G419 Occurrence Handle11171623

    PubMed  Google Scholar 

  • T Kishimoto RN Pearse CR Lin MG Rosenfeld (1995) ArticleTitleA sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle Proc Natl Acad Sci USA 92 1108–1112 Occurrence Handle7755719

    PubMed  Google Scholar 

  • T Kishimoto J Radulovic M Radulovic CR Lin C Schrick F Hooshmand O Hermanson MG Rosenfeld J Spiess (2000) ArticleTitleDeletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 Nat Gen 24 415–419 Occurrence Handle10.1038/74271

    Article  Google Scholar 

  • G Ladds K Davis EW Hillhouse J Davey (2003) ArticleTitleModified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins Mol Microbiol 47 781–792 Occurrence Handle10.1046/j.1365-2958.2003.03336.x Occurrence Handle12535076

    Article  PubMed  Google Scholar 

  • K Lewis C Li MH Perrin A Blount K Kunitake C Donaldson J Vaughan TM Reyes J Gulyas W Fischer L Bilezikjian J Rivier PW Sawchenko WW Vale (2001) ArticleTitleIdentification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor Proc Natl Acad Sci USA 98 7570–7575 Occurrence Handle10.1073/pnas.121165198 Occurrence Handle11416224

    Article  PubMed  Google Scholar 

  • TW Lovenberg DT Chalmers C Liu EB Souza ParticleDe (1995) ArticleTitleCRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues Endocrinology 136 4139–4142 Occurrence Handle10.1210/en.136.9.4139 Occurrence Handle7544278

    Article  PubMed  Google Scholar 

  • GS Lynch (2001) ArticleTitleTherapies for improving muscle function in neuromuscular disorders Exerc Sports Sci Rev 29 141–148 Occurrence Handle10.1097/00003677-200110000-00002

    Article  Google Scholar 

  • MA McAlexander BJ Undem (1997) ArticleTitleEnhancement of tachykinin-induced contractions of guinea pig isolated bronchus by corticotropin-releasing factor Neuropeptides 31 293–299 Occurrence Handle10.1016/S0143-4179(97)90062-7 Occurrence Handle9308014

    Article  PubMed  Google Scholar 

  • S Nava G Gayan-Ramirez H Rollier A Bisschop R Dom V Bock Particlede M Decramer (1996) ArticleTitleEffects of acute steroid administration on ventilatory and peripheral muscles in rats Am J Respir Crit Care Med 153 1888–1896 Occurrence Handle8665051

    PubMed  Google Scholar 

  • MH Perrin WW Vale (1999) ArticleTitleCorticotropin releasing factor receptors and their ligand family Ann NY Acad Sci 885 312–328 Occurrence Handle10816663

    PubMed  Google Scholar 

  • MH Perrin MR DiGruccio SC Koerber JE Rivier KS Kunitake DL Bain WH Fischer WW Vale (2003) ArticleTitleA soluble form of the first extracellular domain of mouse type 2 beta corticotrophin-releasing factor receptor reveals differential ligand specificity J Biol Chem 278 15595–15600 Occurrence Handle10.1074/jbc.M210476200 Occurrence Handle12611895

    Article  PubMed  Google Scholar 

  • Physician Desk Reference (2002) 56th Edition, Montvale, NJ.

  • CJ Rossant RD Pinnock J Hughes MD Hall S McNulty (1999) ArticleTitleCorticotropin-releasing factor type 1 and type 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3,5’-monophosphate response element-binding protein and activation of p42/p44 mitogen activated protein kinase Endocrinology 140 1525–1536 Occurrence Handle10.1210/en.140.4.1525 Occurrence Handle10098484

    Article  PubMed  Google Scholar 

  • OE Rooyackers KS Nair (1997) ArticleTitleHormonal regulation of human muscle protein metabolism Annu Rev Nutr 17 457–485 Occurrence Handle10.1146/annurev.nutr.17.1.457 Occurrence Handle9240936

    Article  PubMed  Google Scholar 

  • R Sharma SD Anker (2002) ArticleTitleCytokines, apoptosis and cachexia: the potential for TNF antagonism Int J Cardiol 85 161–171 Occurrence Handle10.1016/S0167-5273(02)00244-9 Occurrence Handle12163221

    Article  PubMed  Google Scholar 

  • JM Steffen XJ Masucchia (1984) ArticleTitleThymic involution in the suspended rat model for weightlessness: decreased glucocorticoid receptor concentration Physiologist 27 S39–S40 Occurrence Handle11539011

    PubMed  Google Scholar 

  • MJ Tisdale (1997) ArticleTitleBiology of cachexia J Natl Cancer Inst 89 1763–1773 Occurrence Handle10.1093/jnci/89.23.1763 Occurrence Handle9392617

    Article  PubMed  Google Scholar 

  • RR Tremblay MA Ho-Kim C Champagne J Gagnon JY Dube (1986) ArticleTitleVariations of glucocorticoid receptors in intact or denervated muscles: lack of cause–effect relationship with muscle atrophy in the rat J Recept Res 6 183–193 Occurrence Handle3723462

    PubMed  Google Scholar 

  • L Wang V Martinez W Vale Y Tache (2000) ArticleTitleFos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats Brain Res 855 47–57 Occurrence Handle10.1016/S0006-8993(99)02200-3 Occurrence Handle10650129

    Article  PubMed  Google Scholar 

  • LE Wineski DA Deutsch Particlevon IK Abukhalaf SA Pitts DE Potter DF Paulsen (2002) ArticleTitleMuscle specific effects of hindlimb suspension and clenbuterol in mature male rats Cells Tissues Organs 171 188–198 Occurrence Handle10.1159/000063712 Occurrence Handle12097841

    Article  PubMed  Google Scholar 

  • TA Zimmer MV Davies LG Koniaris P Haynes AF Esquela KN Tomkinson AC McPherron NM Wolfman SJ Lee (2002) ArticleTitleInduction of cachexia in mice by systemically administered myostatin Science 296 1486–1488 Occurrence Handle10.1126/science.1069525 Occurrence Handle12029139

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R.J. Isfort.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hinkle, R., Donnelly, E., Cody, D. et al. Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force. J Muscle Res Cell Motil 25, 539–547 (2004). https://doi.org/10.1007/s10974-004-4088-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10974-004-4088-3

Keywords

Navigation